16 publications
| Name | Date | Type | Actions |
|---|---|---|---|
SALES 1st quarter 2024: €134M The Vetoquinol Group recorded sales of €133.7 million in the 1st quarter of fiscal 2024, including €83.4 million for Essential products. |
Public releases | ||
Availability of the 2023 universal registration document On 24 April 2024, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). |
Public releases | ||
2023 ANNUAL RESULTS Annual sales: €529m (stable at constant exchange rates) |
Public releases | ||
Annual sales 2023: €529 million Annual Sales of Essential products: €313 million (up 4.5% at constant exchange rates) |
Public releases | ||
Q3 2018 sales: €90.2 million Vetoquinol wins second prize for CSR in the Gaia Rating In the first nine months of 2018, Vetoquinol recorded sales of €268.1 million, up 3.8% at constant exchange rates and 0.4% as reported. |
Public releases | ||
Vetoquinol takes a major step towards digital innovation by acquiring an equity interest in Farmvet Systems Ltd Vetoquinol, a leading global animal health company, has acquired a majority interest in Farmvet Systems Ltd. A thriving start-up based in Northern Ireland, Farmvet Systems digital know-how enables the strengthening of the role of the veterinary practitioner on cattle farms. |
Public releases | ||
[AUDIO] Présentation des résultats semestriels 2018 - french Vetoquinol - 26.07.2018 - Enregistrement Audio Conference |
Half Year Report | ||
H1 2018 results presentation Slideshow - July 26, 2018 |
Half Year Report | ||
2018 Half year Financial Report 2018 Half year Financial Report |
Half Year Report | ||
First half 2018 results At its meeting on July 25, 2018, the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the audited first half 2018 financial statements. |
Public releases |